bethanechol (urecholine) Report issue

Small molecule Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB

Active Ingredient History

NOW
  • Now
Bethanechol is a parasympathomimetic choline carbamate that selectively stimulates muscarinic receptors with little effect on nicotinic receptors. Bethanechol is indicated for the treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention and for neurogenic atony of the urinary bladder with retention.   NCATS

Chemistry

More Chemistry

Pharmacology

Drug Pricing (per unit)

United States

$0.1171 - $3.6180

Australia

$0.1778
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

2-(carbamoyloxy)-n,n,n-trimethylpropan-1-aminium | 2-carbamoyloxypropyl-trimethylazanium | (2-hydroxypropyl)trimethylammonium carbamate | amidopropyldimethylbetaine | bethanechol | bethanechol chloride | carbamoyl-beta-methylcholine | carbamoyl-β-methylcholine | carbamyl-beta-methylcholine | carbamylmethylcholine chloride | carbamyl-β-methylcholine | duvoid | liberan | myocholine | myotonachol | myotonine | urecholine

Organizations (26)

Research & Development (6)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (20)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (6)

Approved Indications (1)


 

Urinary Retention (approved 1948)

Experimental Indications - Clinical Trial Phases 1-4 (5)


 

Diabetes Mellitus, Type 2 (Phase 1)

Eosinophilic Esophagitis (Phase 2)

Esophageal Motility Disorders (Phase 1)

Pancreatic Neoplasms (Early Phase 1)

Urinary Bladder Diseases (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial Organizations: 6

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue